CA2504310A1 - Method of treating sepsis-induced ards - Google Patents

Method of treating sepsis-induced ards Download PDF

Info

Publication number
CA2504310A1
CA2504310A1 CA002504310A CA2504310A CA2504310A1 CA 2504310 A1 CA2504310 A1 CA 2504310A1 CA 002504310 A CA002504310 A CA 002504310A CA 2504310 A CA2504310 A CA 2504310A CA 2504310 A1 CA2504310 A1 CA 2504310A1
Authority
CA
Canada
Prior art keywords
tetracycline
administered
tetracycline compound
day
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002504310A
Other languages
English (en)
French (fr)
Inventor
Sanford R. Simon
Lorne M. Golub
Hsi-Ming Lee
Gary Nieman
Jay Steinberg
Henry Schiller
Jeff Halter
Anthony Picone
William Marx
Louis Gatto
Charles Lutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2504310A1 publication Critical patent/CA2504310A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002504310A 2002-11-09 2003-11-07 Method of treating sepsis-induced ards Abandoned CA2504310A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/291,194 US20040092491A1 (en) 2002-11-09 2002-11-09 Method of treating sepsis-induced ARDS
US10/291,194 2002-11-09
PCT/US2003/035531 WO2004043228A2 (en) 2002-11-09 2003-11-07 Method of treating sepsis-induced ards

Publications (1)

Publication Number Publication Date
CA2504310A1 true CA2504310A1 (en) 2004-05-27

Family

ID=32229212

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002504310A Abandoned CA2504310A1 (en) 2002-11-09 2003-11-07 Method of treating sepsis-induced ards

Country Status (8)

Country Link
US (1) US20040092491A1 (enExample)
EP (1) EP1567168A2 (enExample)
JP (1) JP2006508128A (enExample)
KR (1) KR20050084960A (enExample)
AU (1) AU2003291367A1 (enExample)
CA (1) CA2504310A1 (enExample)
NZ (1) NZ540497A (enExample)
WO (1) WO2004043228A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003088906A2 (en) * 2002-04-16 2003-10-30 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
US20070010498A1 (en) * 2005-07-07 2007-01-11 Klaus Theobald Method for reducing blood loss associated with cardio-pulmonary bypass surgery
PT2385763T (pt) * 2009-01-12 2018-07-13 Aerpio Therapeutics Inc Métodos para tratar o síndrome de extravasamento vascular
US11103628B1 (en) * 2020-04-29 2021-08-31 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
US10881781B1 (en) 2020-04-29 2021-01-05 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
WO2022191828A1 (en) * 2021-03-10 2022-09-15 Wen Tan NEW USE OF (R)-β2-AGONISTS IN TREATMENT OF SEPSIS AND ACUTE RESPIRATORY DISTRESS SYNDROME
EP4460313A4 (en) * 2022-01-04 2026-01-14 Univ New York State Res Found CMT-3 FORMULATIONS AND THEIR METHODS OF USE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7194894A (en) * 1993-07-20 1995-02-20 Sumio Arai Endotoxin neutralizer
US5773430A (en) * 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline
US5977091A (en) * 1998-09-21 1999-11-02 The Research Foundation Of State University Of New York Method of preventing acute lung injury

Also Published As

Publication number Publication date
US20040092491A1 (en) 2004-05-13
WO2004043228A3 (en) 2005-04-07
AU2003291367A1 (en) 2004-06-03
JP2006508128A (ja) 2006-03-09
KR20050084960A (ko) 2005-08-29
EP1567168A2 (en) 2005-08-31
NZ540497A (en) 2008-02-29
WO2004043228A2 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
Watson et al. Exposure of the peritoneal cavity to air regulates early inflammatory responses to surgery in a murine model
Schmidt et al. Effect of endotoxemia on intestinal villus microcirculation in rats
Brandi et al. Intestinal microflora and digestive toxicity of irinotecan in mice.
KR101380446B1 (ko) 오르니틴 및 페닐아세테이트 또는 페닐부티레이트를 포함한간성 뇌병증 치료용 조성물
US5977091A (en) Method of preventing acute lung injury
Yagci et al. Increased intra-abdominal pressure causes bacterial translocation in rabbits
Snoj et al. Effect of phosphatidylcholine on postoperative adhesions after small bowel anastomosis in the rat
US20040092491A1 (en) Method of treating sepsis-induced ARDS
CN104023719A (zh) 戊二酰组胺用于治疗呼吸道感染的用途
Boermeester et al. Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability-increasing protein
Mason et al. Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms
DE69433848T2 (de) Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems
Sielenkämper et al. The effects of sepsis on gut mucosal blood flow in rats
KR20200010164A (ko) 신규한 글루타미닐 고리화효소 억제제 및 다양한 질환의 치료에서의 이의 용도
JP2006528208A (ja) コンプリメント５ａ受容体阻害剤を使用する出血ショックの処置
Okay et al. N-acetylcysteine attenuates bacterial translocation after partial hepatectomy in rats
CN101102816B (zh) 用于治疗肝性脑病的含有鸟氨酸和苯基乙酸（phenylacetate)或苯基丁酸（phenylbutyrate)的组合物
Bothin et al. The role of the gastrointestinal microflora in postsurgical adhesion formation–a study in germfree rats
Boothe et al. Sclerosing encapsulating peritonitis in three dogs
Takeda et al. Localized oral amyloidosis: ultrastructural and immunohistochemical study
Parsons The role of the glycosaminoglycan layer in bladder defense mechanisms and interstitial cystitis
Fick et al. A surgical model of fulminant hepatic failure in the rabbit: different effects of end-to-side versus small-diameter side-to-side portacaval shunt
Wang et al. Influence of colostomy on in vivo and in vitro permeability of the rat colon
Ünal et al. Effect of granulocyte-macrophage colony stimulating factor on bacterial translocation after experimental obstructive jaundice
Gulcelik et al. Locally applied molgramostim improves wound healing at colonic anastomoses in rats after ligation of the common bile duct

Legal Events

Date Code Title Description
FZDE Discontinued